The Canadian Association for Safe Supply (CASS) has released an infographic to SafeSupply.ca and its social media accounts to highlight potential safety concerns with drug recommendations made in the "Risk Mitigation in the Context of Dual Health Emergencies" prescribing guideline.

CRISM  Medications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic:

This document from Health Canada outlines provincial pharma coverage for selected safe supply drugs:

Dilaudid Tablets monoscript:

M-Eslon monoscript from Ethypharm Pharma:

Road map for establishing a national safe supply program:

BC Election: How the major parties will address the overdose crisis

Posted by Canadian Association For Safe Supply · October 13, 2020 1:38 PM · 1 reaction

Questions about the Overdose Crisis to Ask BC Candidates

Posted by Canadian Association For Safe Supply · September 26, 2020 5:59 PM

Update: Results of BC Budget Consultation 2021

Posted by Canadian Association For Safe Supply · August 21, 2020 3:31 PM